Cholesterol for Interference Testing

• Description:

  Cholesterol for Interference Testing_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_

  Catalog number:	K2010008H
  Lot number:	Batch Dependent
  Expiration date:	Batch Dependent
  Content:	Cholesterol 100 mg
  Appearance:	White Powder
  Application:	Interference Testing
  Shelf-Life	1 year
  Storage:	At -20°C.
  Keywords:	3β-Hydroxy-5-cholestene, 5-Cholesten-3β-ol , cholesterol interference

  _x000D_

  All Interference Products Brochure_x000D_

  _x000D_ _x000D_ _x000D_ References_x000D_

  _x000D_
  • Schiettecatte, J., Anckaert, E., and Smitz, J. (2012). Interferences in Immunoassays. Advances in Immunoassay Technology.
  _x000D_
  • Miller, J. J., and Levinson, S. S. (1996). Interferences In Immunoassays. Immunoassay, 165‚Äì190.
  _x000D_
  • Ward, G. (2013). Rational investigations of immunoassay interferences. Pathology, 45.
  _x000D_
  • Park, J. Y., and Kricka, L. J. (2013). Interferences in Immunoassay. The Immunoassay Handbook, 403‚Äì416.
  _x000D_
  • EP07: Interference Testing in Clinical Chemistry. (2020). Retrieved from https://clsi.org/standards/products/method-evaluation/documents/ep07/.
  _x000D_
  • Gilles A, Frechin L, Natchiar K, Biondani G, Loeffelholz OV, Holvec S, Malaval JL, Winum JY, Klaholz BP, Peyron JF. Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies. Cells. 2020 Mar 5;9(3). pii: E629.
  _x000D_
  • Coussens NP, Auld D, Roby P, Walsh J, Baell JB, Kales S, Hadian K, Dahlin JL. Compound-Mediated Assay Interferences in Homogenous Proximity Assays. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-._x000D_ 2020 Feb 1.
  _x000D_
  • A new approach to overcome natural cholesterol interference during simultaneous determination of two stable isotope-enriched cholesterol tracers in human plasma. Wolff E, Vergnes MF, Kaloustian J, Abou L, Mikail C, Lairon D, Portugal H, Nicolay A. Rapid Commun Mass Spectrom. 2007;21(19):3175-9.
  _x000D_
  • The influence of bilirubin, haemolysis and turbidity on 20 analytical tests performed on automatic analysers. Results of an interlaboratory study. Grafmeyer D, Bondon M, Manchon M, Levillain P. Eur J Clin Chem Clin Biochem. 1995 Jan;33(1):31-52.
  _x000D_
  • Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study. Willeit J, Kiechl S, Santer P, Oberhollenzer F, Egger G, Jarosch E, Mair A. Stroke. 1995 Sep;26(9):1582-7.
  _x000D_

  _x000D_ Related Products_x000D_ _x000D_ https://moleculardepot.com/product/interference-test-kit-extra-for-assay-validation/_x000D_ _x000D_ https://moleculardepot.com/product/interference-test-kit-for-assay-validation/_x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-interference-kit/_x000D_ _x000D_ https://moleculardepot.com/product/hama-interference-kit-for-assay-validation/_x000D_ _x000D_  

• Short Description:

  Catalog #: K2010008H (100 mg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5